Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
76 Leser
Artikel bewerten:
(0)

European Commission Publishes New Guides on Patient Blood Management

BASEL, Switzerland, April 5, 2017 /PRNewswire/ -- On April 3, 2017 the European Commission published two guides on the implementation of Patient Blood Management (PBM); one addressed to national authorities and the other to hospitals. The International Foundation for Patient Blood Management (IFPBM) defines this new standard of care as "an evidence-based bundle of care to optimise medical and surgical patient outcomes by clinically managing and preserving a patient's blood."

On release of their guides the European Commission commented that "the publication is timely as, just last month, the journal Transfusionpublished impressive results (view journal here) from a comprehensive 5-year PBM programme in Western Australia, the world's largest programme to date on PBM. It included 605,046 patients admitted to Western Australia's four major adult tertiary-care hospitals, with results showing a 28% reduction in hospital mortality, a 15% reduction in average hospital length of stay, a 21% decrease in hospital-acquired infections (transfused patients are more susceptible to infection) and a 31% decrease in the incidence of heart attack or stroke. The use of blood products was reduced by 41% during the study period, achieving not only these significant patient outcome benefits but also representing a very substantial cost saving to the health service".

Professor James Isbister, Sydney University Medical School and Senior Advisor to IFPBM, stated "The European Commission guides on Patient Blood Management will help greatly in improving the standard of patient-focused care across Europe. IFPBM is very pleased to see Patient Blood Management implemented in hospitals and medical centers of excellence across Europe and continue to expand into other counties, greatly improving patient care and substantially lowering health care costs."

The guides are expected to greatly enhance the efforts of health authorities and professionals across the European Union to achieve similar results for patients and hospitals as they have in Western Australia.

About IFPBM

The International Foundation for Patient Blood Management (IFPBM) is a Swiss foundation headquartered in Basel, Switzerland. IFPBM is a multi-disciplinary organization whose core purpose is toimprove patient safety and outcomes in clinical practice through optimal Patient Blood Management. IFPBM promotes evidence-based cost-effective practice through education and training, facilitating the highest standard of health care.

About European Commission

The European Commission is one of the main institutions of the European Union (EU). It represents the general interest of the EU, rather than that of individual national governments or political parties. Its core responsibilities include proposing EU laws and policies and monitoring their implementation. Most commission offices are located in Brussels and Luxembourg. The European Commission principles and values guide the commission in its work. These include transparency, language coverage, responsibility towards the environment, equality and ethical behavior. EU policies and laws are carefully designed to bring benefits to citizens, businesses and other stakeholders in the EU.

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.